|
0
|
|
Evaluating Desirability of Outcome Ranking (DOOR) and Win Ratio for Hierarchical Composite Endpoints in Cryptococcal Meningitis Trials.
(academic.oup.com)
|
Dai B
…
Boulware DR
Clinical Infectious Diseases
2026-01-06
|
#infection
#clinical trial
#antifungal
#meningitis
#composite endpoints
|
|
0
|
|
Real-life use of isavuconazole in Spanish children and adolescents.
(academic.oup.com)
|
Mendoza-Palomar N
…
Soler-Palacin P
Journal of Antimicrobial Chemotherapy
2026-01-06
|
#antifungal
#pediatric
#mucormycosis
#therapeuticdrugmonitoring
#invasiveaspergillosis
|
|
0
|
|
Posaconazole enteral tube administration in adults: pharmacokinetic target attainment of oral suspension compared with crushed delayed-release tablet.
(academic.oup.com)
|
Bhattarai N
…
Johnson TM
Journal of Antimicrobial Chemotherapy
2026-01-06
|
#pharmacokinetics
#therapeutics
#antifungal
#drug delivery
|
|
0
|
|
Co-administration of triazoles with calcineurin or mammalian target of rapamycin inhibitors in solid organ transplant patients hospitalized with invasive aspergillosis.
(academic.oup.com)
|
Alexander B
…
Coleman CI
Journal of Antimicrobial Chemotherapy
2026-01-06
|
#immunosuppression
#transplantation
#antifungal
#aspergillosis
#drug-drug interaction
|
|
0
|
|
Efflux-mediated multidrug resistance mechanism in Trichophyton indotineae and Trichophyton rubrum; role of ABC transporters and MFS gene.
(academic.oup.com)
|
Shaw D
…
Rudramurthy SM
Journal of Antimicrobial Chemotherapy
2026-01-06
|
#amr
#antifungal
#transporter
|